Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Phase 3 Completed 309 enrolled Abbott Abbott Japan Co.,Ltd · collab Eisai Inc. · collab

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to assess the long-term safety and tolerability of repeated administration of adalimumab in Japanese subjects with rheumatoid arthritis.

Timeline

Start: 2004-08
Primary completion: 2006-07
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Adalimumab	Monoclonal antibody	40 mg	Subcutaneous

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

Summary

Timeline

Drugs

Indications